[F1] Flash Talks (1)

1:53 PM - 1:54 PM JST(4:53 AM - 4:54 AM UTC)Immunology

[F1-14] An adjuvant database for preclinical evaluation of vaccines and immunotherapeutics

Yayoi Natsume Kitatani^1,2,3, Kouji Kobiyama^4,5,6, Yoshinobu Igarashi⁷, Taiki Aoshi⁸, Noriyuki Nakatsu⁷, Lokesh P Tripathi^1,9, Junichi Ito¹⁰, Johan Nystrom Persson¹¹, Yuji Kosugi¹², Rodolfo S. Allendes Osorio¹³, Chioko Nagao³, *Burcu Temizoz^4,5, Etsushi Kuroda¹⁴, Daron M. Standley¹⁵, Hiroshi Kiyono^16,17,18, Kenji Nakanishi¹⁴, Satoshi Uematsu^19,20, Isao Hamaguchi²¹, Yasuhiro Yasutomi²², Jun Kunisawa²³, Sho Yamasaki^24,25,26,27, Cevayir Coban^5,28,29,30, Hiroshi Yamada⁷, Kenji Mizuguchi³, Ken J Ishii^4,5,29,30 (1. Laboratory of Bioinformatics, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Settsu, Osaka (Japan), 2. Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Tokushima 770-8503, Japan (Japan), 3. Institute for Protein Research, the University of Osaka, Suita, Osaka 565-0871, Japan (Japan), 4. Laboratory of Vaccine Science, the Institute of Medical Science, the University of Tokyo (IMSUT), Minato-ku, Tokyo 108-8639, Japan (Japan), 5. International Vaccine Design Center (VDesC), the Institute of Medical Science, the University of Tokyo (IMSUT), Minato-ku, Tokyo 108-8639, Japan (Japan), 6. Division of Rheumatology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0809, USA (United States of America), 7. Toxicogenomics-Informatics Project, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Settsu, Osaka (Japan), 8. Department of Immunology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan (Japan), 9. RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan (Japan), 10. Discovery Concept Validation Function, Eisai Co., Ltd., Kobe, Hyogo 650-0047, Japan (Japan), 11. JNP Solutions, Sumida-ku, Tokyo 130-0015, Japan (Japan), 12. Lifematics Ltd., Chuo-ku, Tokyo 104-0032, Japan (Japan), 13. Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), the University of Osaka, Suita, Osaka 565-0871, Japan (Japan), 14. Department of Immunology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo 663-8501, Japan (Japan), 15. Department of Genome Informatics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), the University of Osaka, Suita, Osaka 565-0871, Japan (Japan), 16. Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba 260-8670, Japan (Japan), 17. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba, Chiba 260-8670, Japan (Japan), 18. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine, San Diego, CA 92093-0063, USA (United States of America), 19. Department of Immunology and Genomics, Graduate School of Medicine, Osaka Metropolitan University, Abeno, Osaka 545-0051, Japan (Japan), 20. Division of Metagenome Medicine, Human Genome Center, the Institute of Medical Science, the University of Tokyo, Minato-ku, Tokyo 108-8639, Japan (Japan), 21. Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Musashimurayama, Tokyo 208-0011, Japan (Japan), 22. Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Tsukuba, Ibaraki 305-0843, Japan (Japan), 23. Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka 567-0085, Japan (Japan), 24. Department of Molecular Immunology, Research Institute for Microbial Diseases (RIMD), the University of Osaka, Suita, Osaka 565-0871, Japan (Japan), 25. Laboratory of Molecular Immunology, Immunology Frontier Research Center (IFReC), the University of Osaka, Suita, Osaka 565-0871, Japan (Japan), 26. Center for Infectious Disease Education and Research (CiDER), the University of Osaka, Suita, Osaka 565-0871, Japan (Japan), 27. Center for Advanced Modalities and DDS (CAMaD), the University of Osaka, Suita, Osaka 565-0871, Japan (Japan), 28. Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), the University of Tokyo, Tokyo 108-8639, Japan (Japan), 29. WPI Immunology Frontier Research Center (IFReC), the University of Osaka, Suita, Osaka 565-0871, Japan (Japan), 30. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), the University of Tokyo, Tokyo 108-8639, Japan (Japan))

Keywords:

Adjuvant database,Adjuvanticity,Toxicogenomics,FK565

Password required to view

Log in

or